Bibliographic Details
| Title: |
Alcance y limitaciones del tratamiento farmacológico del Trastorno por Déficit de Atención e Hiperactividad en niños y adolescentes y Guías de Práctica Clínica. Una revisión bibliográfica. |
| Alternate Title: |
Outreach and limitations of the pharmacological treatment of Attention Deficit Disorder with Hyperactivity (ADHD) in children and adolescents and Clinical Practice Guidelines. A literature review. |
| Authors: |
Valverde Eizaguirre, Miguel A.1 mvalvere@cfnavarra.es, Inchauspe Aróstegui, José A.2 |
| Source: |
Revista de la Asociación Española de Neuropsiquiatría. ene-mar2014, Vol. 34 Issue 121, p37-74. 38p. |
| Subjects: |
TREATMENT of attention-deficit hyperactivity disorder, STIMULANTS, CHILDREN with attention-deficit hyperactivity disorder, ATTENTION-deficit hyperactivity disorder, ADOLESCENT psychopathology, DRUG side effects |
| Abstract (English): |
The usual story about Attention Deficit Hyperactivity Disorder (ADHD), as stated now currently in Clinical Practice Guidelines (CPGs) and passed on to parents and patients, presents ADHD as a common disorder in childhood and adolescence, with very significant dysfunctional consequences in various areas, and whose main therapeutic approach is based on the use of stimulant drugs considered safe and effective in the long term. These drugs are the same stimulants substances whose harmful consequences are well known in other uses in adults. In this paper we have carried out an exhaustive review of the sources from scientific evidence regarding the short and long term effectiveness of the medication, both over the ADHD nuclear symptoms as functional outcomes and risks arising from potential adverse effects. The result is disappointing and should lead to a modification of the CPGs to the use of drugs as tools of last resort, in a small number of cases and limited and short periods of time. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): |
El Trastorno por Déficit de Atención e Hiperactividad (TDA/H) es descrito y presentado en las Guías de Práctica Clínica (GPC) como frecuente en la infancia y adolescencia, asociado a disfuncionalidad significativa en diversos ámbitos, y cuyo tratamiento requiere usar medicamentos, considerados como seguros y efectivos a largo plazo. Se trata de sustancias estimulantes de cuyo daño, en otro tipo de usos en adultos, se ha alertado. En el presente trabajo se ha procedido a una revisión bibliográfica exhaustiva acerca de las evidencias respecto a su efectividad a corto y largo plazo, sobre la sintomatología nuclear del TDA/H, sus resultados funcionales y los riesgos asociados a sus potenciales efectos adversos. El resultado es desalentador y la utilización de estos medicamentos debería considerarse un último recurso, para un número reducido de casos y en periodos de tiempo limitados y breves. [ABSTRACT FROM AUTHOR] |
|
Copyright of Revista de la Asociación Española de Neuropsiquiatría is the property of Asociacion Espanola de Neuropsiquiatria and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
MedicLatina |
